CRSP vs EFX · rev $11.6M vs P/E 54, rev $3.35B
Crispr Therapeutics AG (CRSP) versus Equifax Inc (EFX) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Equifax Inc (EFX) is a consulting services company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
CRSP currently screens at market cap $5.42B. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Not investment advice. Open the CRSP and EFX stock pages for the full models.
Not investment advice.